ARID1A and liver cancer: Given the frequent presence of the AA‐induced mutational signature SBS22a in HCC patients and the widespread use of AA‐containing herbal medicine in Asia, we investigated whether AA could initiate and promote liver cancer in the context of ARID1A loss.